This look at clinicaltrials.gov indicates head and neck clinical trials are increasingly likely to terminate prior to completion, with later-phase trials evaluating radiation and chemotherapy particularly susceptible to poor accrual, leading the authors to suggest future clinical trial design “would strongly benefit from less stringent inclusion criteria and improved enrollment practices.” | Huang, JAMA Otolaryngol Head Neck Surg 2026
